as of the date of this filing $30 million has alre
Post# of 148288
(Total Views: 586)
Posted On: 09/24/2020 9:31:32 PM
as of the date of this filing $30 million has already been paid.by cydy
The Company estimates that initial ramp-up costs to manufacture commercial grade leronlimab at scale could total approximately $116 million, with approximately $69 million payable over the course of calendar 2020, of which $30 million has been paid as of the date of this filing, and approximately $23 million payable during calendar 2021, and approximately $24 million payable in January of 2022.
The Company estimates that initial ramp-up costs to manufacture commercial grade leronlimab at scale could total approximately $116 million, with approximately $69 million payable over the course of calendar 2020, of which $30 million has been paid as of the date of this filing, and approximately $23 million payable during calendar 2021, and approximately $24 million payable in January of 2022.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼